Artificial Intelligence is no longer a future concept—it’s already shaping how life sciences organizations approach quality management. This session brings together practical insights, regulatory perspectives, and forward-looking strategies to help QA leaders understand where AI is making an impact today, and how to prepare for what’s ahead.

We’ll share real-world use cases where AI is driving measurable improvements in quality operations—examples you can take back to your own teams. You’ll also gain insight into the FDA’s evolving perspective on AI, including recent guidance and the role of initiatives like ELSA (Emerging Technology Program), to better understand the regulatory expectations. Finally, we’ll explore how QA teams can build the skills, processes, and readiness needed to responsibly adopt AI in a compliant, value-driven way.

Whether you’re curious about the technology, actively experimenting with it, or working to align your organization with FDA expectations, this session will give you actionable takeaways to advance your quality strategy with AI.